HEADER RECEPTOR 20-OCT-11 4A4V TITLE LIGAND BINDING DOMAIN OF HUMAN PPAR GAMMA IN COMPLEX WITH AMORFRUTIN 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 195-477; COMPND 5 SYNONYM: PPAR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28A KEYWDS RECEPTOR, AGONIST, DIABETES, INSULIN RESISTANCE EXPDTA X-RAY DIFFRACTION AUTHOR J.C.DE GROOT,C.WEIDNER,J.KRAUSZE,K.KAWAMOTO,F.C.SCHROEDER,S.SAUER, AUTHOR 2 K.BUESSOW REVDAT 3 20-DEC-23 4A4V 1 REMARK REVDAT 2 05-FEB-14 4A4V 1 JRNL REVDAT 1 03-OCT-12 4A4V 0 JRNL AUTH J.C.DE GROOT,C.WEIDNER,J.KRAUSZE,K.KAWAMOTO,F.C.SCHROEDER, JRNL AUTH 2 S.SAUER,K.BUSSOW JRNL TITL STRUCTURAL CHARACTERIZATION OF AMORFRUTINS BOUND TO THE JRNL TITL 2 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA. JRNL REF J.MED.CHEM. V. 56 1535 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23286787 JRNL DOI 10.1021/JM3013272 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 40858 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2151 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3037 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2860 REMARK 3 BIN FREE R VALUE SET COUNT : 160 REMARK 3 BIN FREE R VALUE : 0.3290 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4236 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 247 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.38000 REMARK 3 B22 (A**2) : 1.79000 REMARK 3 B33 (A**2) : -1.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.34000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.195 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.178 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.137 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.761 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4522 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6123 ; 1.219 ; 2.000 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 572 ; 5.365 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 200 ;40.930 ;25.600 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 899 ;14.716 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;17.193 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 701 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3320 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2724 ; 0.672 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4443 ; 1.246 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1798 ; 1.875 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1658 ; 3.130 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 10 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 203 A 249 REMARK 3 ORIGIN FOR THE GROUP (A): -31.7759 7.5398 -47.0318 REMARK 3 T TENSOR REMARK 3 T11: 0.1692 T22: 0.1512 REMARK 3 T33: 0.1687 T12: 0.0344 REMARK 3 T13: -0.0120 T23: -0.0044 REMARK 3 L TENSOR REMARK 3 L11: 1.6551 L22: 0.3898 REMARK 3 L33: 1.6333 L12: 0.7035 REMARK 3 L13: -0.4060 L23: -0.2982 REMARK 3 S TENSOR REMARK 3 S11: -0.1219 S12: 0.1083 S13: -0.0451 REMARK 3 S21: -0.1589 S22: 0.0701 S23: 0.0110 REMARK 3 S31: 0.0389 S32: -0.1788 S33: 0.0518 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 250 A 292 REMARK 3 ORIGIN FOR THE GROUP (A): -13.9551 27.2555 -50.2720 REMARK 3 T TENSOR REMARK 3 T11: 0.3428 T22: 0.2487 REMARK 3 T33: 0.2510 T12: -0.1160 REMARK 3 T13: -0.1432 T23: 0.0049 REMARK 3 L TENSOR REMARK 3 L11: 2.6991 L22: 0.3275 REMARK 3 L33: 3.5353 L12: 0.4263 REMARK 3 L13: -1.8535 L23: -0.2970 REMARK 3 S TENSOR REMARK 3 S11: -0.2281 S12: 0.0054 S13: 0.6469 REMARK 3 S21: -0.1287 S22: 0.2798 S23: 0.1112 REMARK 3 S31: -0.5646 S32: 0.0401 S33: -0.0516 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 293 A 428 REMARK 3 ORIGIN FOR THE GROUP (A): -21.3351 9.1579 -38.4180 REMARK 3 T TENSOR REMARK 3 T11: 0.1278 T22: 0.1393 REMARK 3 T33: 0.1646 T12: 0.0415 REMARK 3 T13: -0.0069 T23: -0.0027 REMARK 3 L TENSOR REMARK 3 L11: 0.6833 L22: 0.6141 REMARK 3 L33: 1.1986 L12: 0.2954 REMARK 3 L13: -0.3383 L23: -0.1331 REMARK 3 S TENSOR REMARK 3 S11: -0.0402 S12: -0.0588 S13: -0.0587 REMARK 3 S21: -0.0430 S22: 0.0386 S23: -0.0942 REMARK 3 S31: -0.0465 S32: 0.0927 S33: 0.0016 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 429 A 466 REMARK 3 ORIGIN FOR THE GROUP (A): -10.8670 12.0686 -36.4557 REMARK 3 T TENSOR REMARK 3 T11: 0.1127 T22: 0.2085 REMARK 3 T33: 0.2120 T12: 0.0589 REMARK 3 T13: -0.0329 T23: -0.0063 REMARK 3 L TENSOR REMARK 3 L11: 1.3017 L22: 5.1526 REMARK 3 L33: 0.6788 L12: 2.5128 REMARK 3 L13: 0.2444 L23: 0.7763 REMARK 3 S TENSOR REMARK 3 S11: -0.0045 S12: -0.1245 S13: -0.1381 REMARK 3 S21: -0.0451 S22: -0.0171 S23: -0.2360 REMARK 3 S31: -0.0482 S32: 0.1542 S33: 0.0216 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 467 A 477 REMARK 3 ORIGIN FOR THE GROUP (A): -14.4127 21.2269 -28.5421 REMARK 3 T TENSOR REMARK 3 T11: 0.2346 T22: 0.3049 REMARK 3 T33: 0.1453 T12: -0.0622 REMARK 3 T13: 0.0322 T23: -0.0795 REMARK 3 L TENSOR REMARK 3 L11: 4.8669 L22: 13.1002 REMARK 3 L33: 14.9397 L12: 1.3021 REMARK 3 L13: 6.2984 L23: -7.6174 REMARK 3 S TENSOR REMARK 3 S11: 0.3165 S12: 0.3754 S13: -0.2544 REMARK 3 S21: 1.3766 S22: -0.3940 S23: -0.5453 REMARK 3 S31: -0.6601 S32: 0.9152 S33: 0.0774 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 206 B 239 REMARK 3 ORIGIN FOR THE GROUP (A): -11.0655 -22.0696 -24.0005 REMARK 3 T TENSOR REMARK 3 T11: 0.1758 T22: 0.1089 REMARK 3 T33: 0.1881 T12: 0.0474 REMARK 3 T13: -0.0053 T23: 0.0460 REMARK 3 L TENSOR REMARK 3 L11: 1.6163 L22: 1.6835 REMARK 3 L33: 2.3477 L12: 0.4340 REMARK 3 L13: 0.1208 L23: 0.2146 REMARK 3 S TENSOR REMARK 3 S11: 0.0418 S12: -0.2779 S13: -0.1209 REMARK 3 S21: -0.0131 S22: -0.0004 S23: 0.0703 REMARK 3 S31: 0.3466 S32: -0.0989 S33: -0.0415 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 240 B 270 REMARK 3 ORIGIN FOR THE GROUP (A): 7.7451 -11.3784 -5.5841 REMARK 3 T TENSOR REMARK 3 T11: 0.1325 T22: 0.5322 REMARK 3 T33: 0.1725 T12: 0.0221 REMARK 3 T13: -0.0314 T23: 0.1819 REMARK 3 L TENSOR REMARK 3 L11: 2.5730 L22: 0.6963 REMARK 3 L33: 6.6737 L12: -1.0373 REMARK 3 L13: -1.0087 L23: 0.8350 REMARK 3 S TENSOR REMARK 3 S11: 0.2003 S12: -0.5931 S13: -0.5793 REMARK 3 S21: -0.0993 S22: -0.0586 S23: 0.1545 REMARK 3 S31: 0.2596 S32: 0.6505 S33: -0.1417 REMARK 3 REMARK 3 TLS GROUP : 8 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 275 B 359 REMARK 3 ORIGIN FOR THE GROUP (A): 1.6291 -9.0938 -22.9087 REMARK 3 T TENSOR REMARK 3 T11: 0.1393 T22: 0.1727 REMARK 3 T33: 0.1608 T12: 0.0342 REMARK 3 T13: 0.0110 T23: -0.0019 REMARK 3 L TENSOR REMARK 3 L11: 0.6225 L22: 0.4351 REMARK 3 L33: 1.9441 L12: -0.0565 REMARK 3 L13: 0.0224 L23: 0.2976 REMARK 3 S TENSOR REMARK 3 S11: 0.0237 S12: -0.1291 S13: 0.0387 REMARK 3 S21: 0.0531 S22: -0.0063 S23: -0.0445 REMARK 3 S31: -0.1227 S32: 0.1854 S33: -0.0174 REMARK 3 REMARK 3 TLS GROUP : 9 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 360 B 437 REMARK 3 ORIGIN FOR THE GROUP (A): -12.7923 -9.8946 -29.1292 REMARK 3 T TENSOR REMARK 3 T11: 0.1323 T22: 0.1308 REMARK 3 T33: 0.1701 T12: 0.0550 REMARK 3 T13: 0.0084 T23: 0.0073 REMARK 3 L TENSOR REMARK 3 L11: 1.1707 L22: 0.4714 REMARK 3 L33: 0.9580 L12: -0.1602 REMARK 3 L13: -0.0775 L23: -0.0340 REMARK 3 S TENSOR REMARK 3 S11: 0.0272 S12: -0.0763 S13: 0.0845 REMARK 3 S21: -0.0040 S22: 0.0121 S23: 0.0852 REMARK 3 S31: -0.0128 S32: -0.0599 S33: -0.0393 REMARK 3 REMARK 3 TLS GROUP : 10 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 438 B 474 REMARK 3 ORIGIN FOR THE GROUP (A): 7.3771 0.7992 -26.2141 REMARK 3 T TENSOR REMARK 3 T11: 0.1740 T22: 0.2407 REMARK 3 T33: 0.3874 T12: 0.0176 REMARK 3 T13: 0.0504 T23: 0.0519 REMARK 3 L TENSOR REMARK 3 L11: 0.7351 L22: 1.3423 REMARK 3 L33: 1.2805 L12: 0.6451 REMARK 3 L13: -0.7723 L23: -1.2803 REMARK 3 S TENSOR REMARK 3 S11: 0.2169 S12: 0.0360 S13: 0.3138 REMARK 3 S21: 0.1810 S22: -0.2021 S23: -0.1145 REMARK 3 S31: -0.2097 S32: 0.1736 S33: -0.0148 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4A4V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-OCT-11. REMARK 100 THE DEPOSITION ID IS D_1290049948. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5419 REMARK 200 MONOCHROMATOR : RIGAKU VARIMAX REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU-MSC SATURN 944 PLUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43005 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 27.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.56000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1PRG REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8 M TRI-SODIUM CITRATE, 0.1 M REMARK 280 IMIDAZOLE, PH 8.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.14500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.48500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.14500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.48500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 191 REMARK 465 SER A 192 REMARK 465 HIS A 193 REMARK 465 MET A 194 REMARK 465 ALA A 195 REMARK 465 GLU A 196 REMARK 465 ILE A 197 REMARK 465 SER A 198 REMARK 465 SER A 199 REMARK 465 ASP A 200 REMARK 465 ILE A 201 REMARK 465 ASP A 202 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 GLY B 191 REMARK 465 SER B 192 REMARK 465 HIS B 193 REMARK 465 MET B 194 REMARK 465 ALA B 195 REMARK 465 GLU B 196 REMARK 465 ILE B 197 REMARK 465 SER B 198 REMARK 465 SER B 199 REMARK 465 ASP B 200 REMARK 465 ILE B 201 REMARK 465 ASP B 202 REMARK 465 GLN B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 ASP B 475 REMARK 465 LEU B 476 REMARK 465 TYR B 477 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 241 121.57 -170.56 REMARK 500 GLU A 259 43.66 -71.90 REMARK 500 ASP A 310 129.02 -37.86 REMARK 500 GLU A 460 67.90 -115.81 REMARK 500 THR B 241 -108.09 -128.48 REMARK 500 LYS B 261 -77.30 -67.01 REMARK 500 PRO B 269 56.15 -65.61 REMARK 500 THR B 459 -31.03 -132.79 REMARK 500 MET B 463 77.06 -117.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS A 240 THR A 241 -147.70 REMARK 500 THR A 241 THR A 242 140.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YFD A 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YFD B 999 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FVJ RELATED DB: PDB REMARK 900 A NOVEL ANTI-ADIPOGENIC PARTIAL AGONIST OF PEROXISOMEPROLIFERATOR- REMARK 900 ACTIVATED RECEPTOR-GAMMA (PPARG) RECRUITSPPARG-COACTIVATOR-1 ALPHA REMARK 900 (PGC1A) BUT POTENTIATES INSULINSIGNALING IN VITRO REMARK 900 RELATED ID: 2VV2 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 5- HEPA REMARK 900 RELATED ID: 1FM9 RELATED DB: PDB REMARK 900 THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THEHETERODIMER OF REMARK 900 THE HUMAN RXRALPHA AND PPARGAMMA LIGANDBINDING DOMAINS RESPECTIVELY REMARK 900 BOUND WITH 9-CIS RETINOIC ACIDAND GI262570 AND CO-ACTIVATOR REMARK 900 PEPTIDES. REMARK 900 RELATED ID: 2XKW RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE REMARK 900 AGONIST PIOGLITAZONE REMARK 900 RELATED ID: 2VV0 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH DHA REMARK 900 RELATED ID: 2VV1 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4- HDHA REMARK 900 RELATED ID: 1KNU RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATORACTIVATED REMARK 900 RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETICAGONIST REMARK 900 RELATED ID: 2PRG RELATED DB: PDB REMARK 900 LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR REMARK 900 ACTIVATED RECEPTOR GAMMA REMARK 900 RELATED ID: 1RDT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A NEW REXINOID BOUND TO THE RXRALPHALIGAND REMARK 900 BINDING DOAMIN IN THE RXRALPHA/PPARGAMMA HETERODIMER REMARK 900 RELATED ID: 3PRG RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1I7I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMANPPAR-GAMMA REMARK 900 IN COMPLEX WITH THE AGONIST AZ 242 REMARK 900 RELATED ID: 2VV4 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 6- OXOOTE REMARK 900 RELATED ID: 1K74 RELATED DB: PDB REMARK 900 THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THEHETERODIMER OF REMARK 900 THE HUMAN PPARGAMMA AND RXRALPHA LIGANDBINDING DOMAINS RESPECTIVELY REMARK 900 BOUND WITH GW409544 AND 9-CISRETINOIC ACID AND CO-ACTIVATOR REMARK 900 PEPTIDES. REMARK 900 RELATED ID: 1FM6 RELATED DB: PDB REMARK 900 THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THEHETERODIMER OF REMARK 900 THE HUMAN RXRALPHA AND PPARGAMMA LIGANDBINDING DOMAINS RESPECTIVELY REMARK 900 BOUND WITH 9-CIS RETINOIC ACIDAND ROSIGLITAZONE AND CO-ACTIVATOR REMARK 900 PEPTIDES. REMARK 900 RELATED ID: 1PRG RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR REMARK 900 ACTIVATED RECEPTOR GAMMA REMARK 900 RELATED ID: 1ZGY RELATED DB: PDB REMARK 900 STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSIONOF THE REMARK 900 ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP REMARK 900 RELATED ID: 2F4B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMANPPAR-GAMMA REMARK 900 IN COMPLEX WITH AN AGONIST REMARK 900 RELATED ID: 2VST RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 13-(S )-HODE REMARK 900 RELATED ID: 2G0H RELATED DB: PDB REMARK 900 STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPARPARTIAL REMARK 900 AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHYAND IN VITRO/IN REMARK 900 VIVO BIOLOGICAL ACTIVITIES REMARK 900 RELATED ID: 2VSR RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 9-(S )-HODE REMARK 900 RELATED ID: 1WM0 RELATED DB: PDB REMARK 900 PPARGAMMA IN COMPLEX WITH A 2-BABA COMPOUND REMARK 900 RELATED ID: 4PRG RELATED DB: PDB REMARK 900 0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL REMARK 900 RELATED ID: 1NYX RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATORACTIVATED REMARK 900 RECEPTOR GAMMA IN COMPLEX WITH AN AGONIST REMARK 900 RELATED ID: 2G0G RELATED DB: PDB REMARK 900 STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPARPARTIAL REMARK 900 AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHYAND IN VITRO/IN REMARK 900 VIVO BIOLOGICAL ACTIVITIES REMARK 900 RELATED ID: 2VV3 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4- OXODHA REMARK 900 RELATED ID: 2YFE RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF HUMAN PPAR GAMMA IN COMPLEX WITH REMARK 900 AMORFRUTIN 1 REMARK 900 RELATED ID: 4A4W RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF HUMAN PPAR GAMMA IN COMPLEX WITH REMARK 900 AMORFRUTIN B DBREF 4A4V A 195 477 UNP P37231 PPARG_HUMAN 195 477 DBREF 4A4V B 195 477 UNP P37231 PPARG_HUMAN 195 477 SEQADV 4A4V GLY A 191 UNP P37231 EXPRESSION TAG SEQADV 4A4V SER A 192 UNP P37231 EXPRESSION TAG SEQADV 4A4V HIS A 193 UNP P37231 EXPRESSION TAG SEQADV 4A4V MET A 194 UNP P37231 EXPRESSION TAG SEQADV 4A4V GLY B 191 UNP P37231 EXPRESSION TAG SEQADV 4A4V SER B 192 UNP P37231 EXPRESSION TAG SEQADV 4A4V HIS B 193 UNP P37231 EXPRESSION TAG SEQADV 4A4V MET B 194 UNP P37231 EXPRESSION TAG SEQRES 1 A 287 GLY SER HIS MET ALA GLU ILE SER SER ASP ILE ASP GLN SEQRES 2 A 287 LEU ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS SEQRES 3 A 287 HIS LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR SEQRES 4 A 287 LYS ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR SEQRES 5 A 287 ASP LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU SEQRES 6 A 287 MET MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR SEQRES 7 A 287 PRO LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE SEQRES 8 A 287 PHE GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN SEQRES 9 A 287 GLU ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL SEQRES 10 A 287 ASN LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR SEQRES 11 A 287 GLY VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU SEQRES 12 A 287 MET ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY SEQRES 13 A 287 PHE MET THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO SEQRES 14 A 287 PHE GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL SEQRES 15 A 287 LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA SEQRES 16 A 287 ILE PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO SEQRES 17 A 287 GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP SEQRES 18 A 287 ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN SEQRES 19 A 287 HIS PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN SEQRES 20 A 287 LYS MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL SEQRES 21 A 287 GLN LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SEQRES 22 A 287 SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU SEQRES 23 A 287 TYR SEQRES 1 B 287 GLY SER HIS MET ALA GLU ILE SER SER ASP ILE ASP GLN SEQRES 2 B 287 LEU ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS SEQRES 3 B 287 HIS LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR SEQRES 4 B 287 LYS ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR SEQRES 5 B 287 ASP LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU SEQRES 6 B 287 MET MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR SEQRES 7 B 287 PRO LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE SEQRES 8 B 287 PHE GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN SEQRES 9 B 287 GLU ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL SEQRES 10 B 287 ASN LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR SEQRES 11 B 287 GLY VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU SEQRES 12 B 287 MET ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY SEQRES 13 B 287 PHE MET THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO SEQRES 14 B 287 PHE GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL SEQRES 15 B 287 LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA SEQRES 16 B 287 ILE PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO SEQRES 17 B 287 GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP SEQRES 18 B 287 ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN SEQRES 19 B 287 HIS PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN SEQRES 20 B 287 LYS MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL SEQRES 21 B 287 GLN LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SEQRES 22 B 287 SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU SEQRES 23 B 287 TYR HET YFD A 999 22 HET YFD B 999 22 HETNAM YFD AMORFRUTIN 2 FORMUL 3 YFD 2(C18 H26 O4) FORMUL 5 HOH *247(H2 O) HELIX 1 1 PRO A 206 SER A 225 1 20 HELIX 2 2 LYS A 230 THR A 238 1 9 HELIX 3 3 MET A 252 GLY A 258 1 7 HELIX 4 4 VAL A 277 SER A 302 1 26 HELIX 5 5 LEU A 311 SER A 332 1 22 HELIX 6 6 ARG A 350 LYS A 354 1 5 HELIX 7 7 GLU A 365 ASN A 375 1 11 HELIX 8 8 ASP A 381 ILE A 392 1 12 HELIX 9 9 VAL A 403 ASN A 424 1 22 HELIX 10 10 LEU A 431 THR A 459 1 29 HELIX 11 11 PRO A 467 TYR A 473 1 7 HELIX 12 12 ALA B 209 SER B 225 1 17 HELIX 13 13 LYS B 230 LEU B 237 1 8 HELIX 14 14 MET B 252 LYS B 261 1 10 HELIX 15 15 VAL B 277 LYS B 301 1 25 HELIX 16 16 LEU B 311 ALA B 331 1 21 HELIX 17 17 ARG B 350 LYS B 354 1 5 HELIX 18 18 GLU B 365 ASN B 375 1 11 HELIX 19 19 ASP B 381 ILE B 392 1 12 HELIX 20 20 VAL B 403 ASN B 424 1 22 HELIX 21 21 LEU B 431 THR B 459 1 29 HELIX 22 22 PRO B 467 ILE B 472 1 6 SHEET 1 1 1 PHE A 247 ILE A 249 0 SHEET 1 2 1 MET A 334 ASN A 335 0 SHEET 1 3 1 GLY A 338 ILE A 341 0 SHEET 1 4 1 GLY A 346 THR A 349 0 SHEET 1 5 1 PHE B 247 ILE B 249 0 SHEET 1 6 1 MET B 334 ASN B 335 0 SHEET 1 7 1 GLY B 338 ILE B 341 0 SHEET 1 8 1 GLY B 346 THR B 349 0 CISPEP 1 LYS A 358 PRO A 359 0 -0.71 CISPEP 2 LYS B 358 PRO B 359 0 -1.37 CISPEP 3 MET B 463 SER B 464 0 -5.02 SITE 1 AC1 6 CYS A 285 ARG A 288 ILE A 341 SER A 342 SITE 2 AC1 6 MET A 348 HOH A2077 SITE 1 AC2 9 CYS B 285 ARG B 288 ALA B 292 ILE B 326 SITE 2 AC2 9 MET B 329 LEU B 330 LEU B 333 LEU B 340 SITE 3 AC2 9 HOH B2069 CRYST1 92.290 60.970 117.900 90.00 102.65 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010835 0.000000 0.002432 0.00000 SCALE2 0.000000 0.016402 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008693 0.00000 MTRIX1 1 0.099940 0.976510 0.190920 -5.31640 1 MTRIX2 1 0.983810 -0.125670 0.127790 16.95024 1 MTRIX3 1 0.148780 0.175050 -0.973250 -62.43509 1